Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Endometrioid

Explore clinical trials studying Carcinoma, Endometrioid. Study availability and eligibility vary by location and protocol.

19 public trials 5 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Endometrioid trial results

Completed

Copanlisib in Treating Patients With Persistent or Recurrent Endometrial Cancer

NCT02728258

Conditions
Adenocarcinoma, Adnexal Diseases, Carcinoma, +24 more
Locations
  • Yale University New Haven, Connecticut, United States
  • UM Sylvester Comprehensive Cancer Center at Deerfield Beach Deerfield Beach, Florida, United States
  • University of Miami Miller School of Medicine-Sylvester Cancer Center Miami, Florida, United States
  • Northside Hospital Atlanta, Georgia, United States
View all 43 locations
View Trial Details
Active, Not Recruiting

Testing the Combination of Olaparib and Durvalumab, Cediranib and Durvalumab, Olaparib and Capivasertib, and Cediranib Alone in Recurrent or Refractory Endometrial Cancer Following the Earlier Phase of the Study That Tested Olaparib and Cediranib in Comparison to Cediranib Alone, and Olaparib Alone

NCT03660826

Conditions
Adenocarcinoma, Adnexal Diseases, Carcinoma, +28 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
View all 762 locations
View Trial Details
Active, Not Recruiting

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

NCT02834013

Conditions
Acinar Cell Carcinoma, Adenocarcinoma, Adenocarcinoma of Lung, +207 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
View all 1007 locations
View Trial Details
Active, Not Recruiting

Evaluation of Sentinel Node Policy in Early Stage Endometrial Carcinomas at Intermediate and High Risk of Recurrence.

NCT02598219

Conditions
Adenocarcinoma, Adnexal Diseases, Carcinoma, +20 more
Locations
  • Polyclinique Urbain V Avignon, France
  • Centre Hospitalier Régional Universitaire Besançon, France
  • Institut Bergonié Bordeaux, France
  • Centre Jean Perrin Clermont-Ferrand, France
View all 16 locations
View Trial Details
Active, Not Recruiting

Phase I Trial of Defactinib and VS-6766.

NCT03875820

Conditions
Adenocarcinoma, Adnexal Diseases, Carcinoma, +27 more
Locations
  • The Christie NHS Foundation Trust Manchester, Greater Manchester, United Kingdom
  • The Royal Marsden NHS Foundation Trust Sutton, Surrey, United Kingdom
  • The Royal Marsden NHS Foundation Trust - Gynecology Unit London, United Kingdom
  • The Newcastle Upon Tyne Hospitals NHS Foundation Trust - Freeman Hospital Newcastle, United Kingdom
View Trial Details
Active, Not Recruiting

ATr Inhibitor in Combination With Olaparib/Durvalumab (MEDI4736) in Gynaecological Cancers With ARId1A Loss or no Loss

NCT04065269

Conditions
Adenocarcinoma, Adnexal Diseases, Carcinoma, +26 more
Locations
  • The Ottawa Hospital Cancer Centre Ottawa, Ontario, Canada
  • Princess Margaret Cancer Centre Toronto, Ontario, Canada
  • University of Montreal Hospital Centre Montreal, Quebec, Canada
  • Royal United Hospital Bath, United Kingdom
View Trial Details

Related conditions